• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CD44 激活在癌症进展和治疗靶向中的状态。

The state of CD44 activation in cancer progression and therapeutic targeting.

机构信息

Department of Molecular Biology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

Department of Clinical Laboratory, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.

出版信息

FEBS J. 2022 Dec;289(24):7970-7986. doi: 10.1111/febs.16179. Epub 2021 Sep 19.

DOI:10.1111/febs.16179
PMID:34478583
Abstract

CD44, a non-kinase transmembrane glycoprotein, is ubiquitously expressed on various types of cells, especially cancer stem cells (CSCs), and has been implicated in cancer onset and aggressiveness. The major ligand for the CD44, hyaluronan (HA), binds to and interacts with CD44, which in turn triggers downstream signaling cascades, thereby promoting cellular behaviors such as proliferation, motility, invasiveness and chemoresistance. The CD44-HA interaction is cell-specific and strongly affected by the state of CD44 activation. Therefore, the binding of HA to CD44 is essential for the activation of CD44 during which the detailed regulatory mechanism needs to be clarified. Different CD44 activation states distribute in human carcinoma and normal tissue; however, whether CD44 activation is a critical requirement for tumor initiation, progression and notorious CSC properties remains to be clarified. A deeper understanding of the regulation of CD44 activation may facilitate the development of novel targeted drugs in the future. Here, we review the current findings concerning the states of CD44 activation on the cell surface, the underlying regulatory mechanisms of CD44 activation, the known role for CD44 activation in tumor progression and CSC hallmarks, as well as the potential of HA-coated nanoparticle for targeting activated CD44 for cancer therapy.

摘要

CD44 是一种非激酶跨膜糖蛋白,广泛表达于各种类型的细胞上,尤其是癌症干细胞(CSC),并与癌症的发生和侵袭性有关。CD44 的主要配体透明质酸(HA)与 CD44 结合并相互作用,进而触发下游信号级联反应,从而促进细胞增殖、迁移、侵袭和耐药等行为。CD44-HA 相互作用具有细胞特异性,并受 CD44 激活状态的强烈影响。因此,HA 与 CD44 的结合对于 CD44 的激活至关重要,在此过程中需要阐明详细的调节机制。不同的 CD44 激活状态分布于人类癌组织和正常组织中;然而,CD44 的激活是否是肿瘤起始、进展和恶性 CSC 特性的关键要求仍有待阐明。深入了解 CD44 激活的调节机制可能有助于未来开发新型靶向药物。本文综述了细胞表面 CD44 激活状态、CD44 激活的潜在调节机制、CD44 激活在肿瘤进展和 CSC 特征中的已知作用,以及针对激活的 CD44 的 HA 包覆纳米颗粒在癌症治疗中的潜在应用。

相似文献

1
The state of CD44 activation in cancer progression and therapeutic targeting.CD44 激活在癌症进展和治疗靶向中的状态。
FEBS J. 2022 Dec;289(24):7970-7986. doi: 10.1111/febs.16179. Epub 2021 Sep 19.
2
Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.基质透明质酸介导的CD44信号激活、表观遗传调控与头颈癌干细胞的化疗耐药性
Int J Mol Sci. 2017 Aug 24;18(9):1849. doi: 10.3390/ijms18091849.
3
Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.透明质酸与CD44的相互作用促进癌干细胞中的致癌信号传导、微小RNA功能、化学抗性和辐射抗性,从而导致肿瘤进展。
Adv Cancer Res. 2014;123:255-75. doi: 10.1016/B978-0-12-800092-2.00010-1.
4
A Novel Therapeutic siRNA Nanoparticle Designed for Dual-Targeting CD44 and Gli1 of Gastric Cancer Stem Cells.一种新型治疗性 siRNA 纳米颗粒,设计用于双重靶向胃癌干细胞的 CD44 和 Gli1。
Int J Nanomedicine. 2020 Sep 23;15:7013-7034. doi: 10.2147/IJN.S260163. eCollection 2020.
5
Cancer Cell CD44 Mediates Macrophage/Monocyte-Driven Regulation of Head and Neck Cancer Stem Cells.肿瘤细胞 CD44 介导巨噬细胞/单核细胞对头颈部癌症干细胞的调控作用。
Cancer Res. 2020 Oct 1;80(19):4185-4198. doi: 10.1158/0008-5472.CAN-20-1079. Epub 2020 Aug 14.
6
CD44 activation state regulated by the CD44v10 isoform determines breast cancer proliferation.CD44v10 异构体调控的 CD44 激活状态决定乳腺癌的增殖。
Oncol Rep. 2021 Apr;45(4). doi: 10.3892/or.2021.7958. Epub 2021 Mar 2.
7
Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.透明质酸-CD44 相互作用促进 c-Src 介导的 twist 信号转导、microRNA-10b 的表达以及 RhoA/RhoC 的上调,导致 Rho 激酶相关细胞骨架激活和乳腺癌细胞侵袭。
J Biol Chem. 2010 Nov 19;285(47):36721-35. doi: 10.1074/jbc.M110.162305. Epub 2010 Sep 15.
8
Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.透明质酸合成酶/透明质酸/CD44分子系统在癌症中的作用及靶向性
Matrix Biol. 2017 May;59:3-22. doi: 10.1016/j.matbio.2016.10.001. Epub 2016 Oct 13.
9
Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells.透明质酸-CD44与白血病相关的Rho鸟苷酸交换因子和表皮生长因子受体的相互作用促进头颈部鳞状细胞癌细胞中的Rho/Ras共激活、磷脂酶Cε-Ca2+信号传导和细胞骨架修饰。
J Biol Chem. 2006 May 19;281(20):14026-40. doi: 10.1074/jbc.M507734200. Epub 2006 Mar 24.
10
Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.干细胞标志物(Nanog)和 Stat-3 信号通路促进透明质酸/CD44 激活的头颈部鳞状细胞癌细胞中 MicroRNA-21 的表达和化疗耐药性。
Oncogene. 2012 Jan 12;31(2):149-60. doi: 10.1038/onc.2011.222. Epub 2011 Jun 20.

引用本文的文献

1
Eicosapentaenoic acid restores inflammation-induced changes in chondrocyte mechanics by suppressing the NF-κB p65/CD44 signaling pathway and attenuates osteoarthritis.二十碳五烯酸通过抑制NF-κB p65/CD44信号通路恢复炎症诱导的软骨细胞力学变化,并减轻骨关节炎。
Exp Mol Med. 2025 Sep 1. doi: 10.1038/s12276-025-01529-7.
2
CD44 signaling in skin wound healing and regeneration.皮肤伤口愈合与再生中的CD44信号传导
J Transl Med. 2025 Aug 7;23(1):880. doi: 10.1186/s12967-025-06913-5.
3
Transformable self-assembling peptide nanoplatforms with tumor microenvironment responsiveness for tumor stem cell suppression and immunomodulation.
具有肿瘤微环境响应性的可转化自组装肽纳米平台用于抑制肿瘤干细胞和免疫调节。
Mater Today Bio. 2025 Jul 10;33:102078. doi: 10.1016/j.mtbio.2025.102078. eCollection 2025 Aug.
4
Hyaluronic Acid-Functionalized Bismuth Vanadate/Molybdenum Disulfide Nanoheterojunctions Achieve Efficient Phototherapy of Hypoxic Tumor.透明质酸功能化钒酸铋/二硫化钼纳米异质结实现对缺氧肿瘤的高效光疗
Biomater Res. 2025 Jul 18;29:0228. doi: 10.34133/bmr.0228. eCollection 2025.
5
Statins and adhesion molecules: a review of a novel pleiotropic property of statins.他汀类药物与黏附分子:他汀类药物一种新的多效性特性综述
Immunol Res. 2025 Jun 17;73(1):97. doi: 10.1007/s12026-025-09653-2.
6
HPV16 E7 Enhances Cell Stemness via RTKN2-Mediated Activation of the NF-κB Pathway in Cervical Cancer.人乳头瘤病毒16型E7蛋白通过RTKN2介导的核因子κB信号通路激活增强宫颈癌的细胞干性
Biochem Genet. 2025 Jun 10. doi: 10.1007/s10528-025-11144-w.
7
Hyaluronic acid-engineered milk extracellular vesicles to target triple negative breast cancer through CD44.透明质酸工程化的牛奶细胞外囊泡通过CD44靶向三阴性乳腺癌。
Pharm Biol. 2025 Dec;63(1):411-427. doi: 10.1080/13880209.2025.2511807. Epub 2025 Jun 5.
8
Drug-tolerant persister cells in acute myeloid leukemia: pressing challenge and promising new strategies for treatment.急性髓系白血病中的药物耐受性持久细胞:紧迫的挑战与有前景的新治疗策略
Front Med (Lausanne). 2025 May 14;12:1586552. doi: 10.3389/fmed.2025.1586552. eCollection 2025.
9
Anti-metastatic potential of flavonoids for the treatment of cancers: focus on epithelial-mesenchymal transition (EMT) process.黄酮类化合物治疗癌症的抗转移潜力:聚焦于上皮-间质转化(EMT)过程。
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 28. doi: 10.1007/s00210-025-04235-3.
10
Targeting LHPP in neoadjuvant chemotherapy resistance of gastric cancer: insights from single-cell and multi-omics data on tumor immune microenvironment and stemness characteristics.靶向LHPP在胃癌新辅助化疗耐药中的作用:来自肿瘤免疫微环境和干性特征的单细胞及多组学数据的见解
Cell Death Dis. 2025 Apr 16;16(1):306. doi: 10.1038/s41419-025-07614-z.